Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint

As a head-to-head Phase III trial comparing sac-TMT plus pembrolizumab with the…

Globe Bags Back-to-Back Recognition in TIME's World's Most Sustainable Companies, Remains Only Philippine Telco on Global List

TAGUIG CITY, Philippines, July 15, 2026 /PRNewswire/ — For the second consecutive…

The University of Western Australia appoints SRM Technologies as Information Technology Partner for its India Branch Campuses

Admissions now open at https://bit.ly/4wBV333 for UWA India’s Mumbai and Chennai campuses, with…

Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development

Combines Insilico’s Pharma.AI platform with Bora’s global development, manufacturing, quality, and commercialization…

Allianz Worldwide Partners Japan reveals new logo and company name under the Allianz brand

Strategic simplification of brand portfolio aligns Japan operations with global Allianz brand,…

Lynk Pharmaceuticals Announces Completion of Patient Enrollment in Phase III Clinical Trial of Zemprocitinib for Ankylosing Spondylitis

HANGZHOU, China and SHANGHAI and BOSTON, July 15, 2026 /PRNewswire/ — Lynk…

Monport Highlights the Growing Shift from Hobby Lasers to Production-Ready Desktop CO2 Laser Systems with the MEGAS

CHICAGO, July 15, 2026 /PRNewswire/ — As more makers and small businesses…

ACROBiosystems Obtains PMDA Material Suitability Confirmation for GMP-grade IL-15, Ensuring Reliable Quality and Strengthening the Biopharmaceutical Approval Process

NEWARK, Del., July 15, 2026 /PRNewswire/ — Recently, ACROBiosystems has officially received…